by Ellee Seymour | Mar 7, 2012 | Blog, PR client
The British life science industry is thwarted by lack of investment with a slow regulatory process which is impeding its development, said Sir Christopher Evans, the biotech king who is regarded as one of Europe’s leading medical science entrepreneurs, if not...
Recent Comments